iFIT Seminar Series with Dr. Anna Obenauf
Towards mechanism-based therapy combinations: Understanding tumor evolution during therapy response and resistance
On behalf of the iFIT spokespersons Lars Zender, Hans-Georg Rammensee and Bernd Pichler, it is our pleasure to inform you about and invite you to the next episode of our iFIT Seminar Series 2023 that will take place
on Monday, June 26th at 12:30 pm s.t. (CEST)
at the big lecture hall in the Medical Clinic (Otfried-Müller-Straße 10, Kliniken Berg).
Our guest speaker Dr. Anna Obenauf from the Research Institute of Molecular Pathology in Vienna will give a talk on
“Towards mechanism-based therapy combinations: Understanding tumor evolution during therapy response and resistance”.
Targeted therapies and immunotherapies have transformed the clinical care of patients with metastatic cancer. By optimizing treatment with combinations of different therapies, a cure appears within reach for many cancers. However, achieving this goal will require more detailed knowledge of the mechanisms of therapy resistance and immune evasion and, importantly, of the impact of therapies on tumor evolution, which may promote or prevent subsequent therapy responses. The vision of my lab is to build and exploit this knowledge to identify rational combinations of existing and emerging therapies by understanding the complex and dynamic biology of cancer cells and the tumor microenvironment in all phases of therapy.
As a special feature of this program, the iFIT will sponsor free lunch packages! (First come, first serve)
All members of the University Hospital and University of Tübingen are invited to participate!
We look forward to this Seminar Series session and to see you there!
